Northeast Financial Consultants’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,188
| Closed | -$17K | – | 302 |
|
|
2025
Q1 | $17K | Hold |
2,188
| – | – | ﹤0.01% | 276 |
|
|
2024
Q4 | $29K | Hold |
2,188
| – | – | ﹤0.01% | 285 |
|
|
2024
Q3 | $21.8K | Hold |
2,188
| – | – | ﹤0.01% | 291 |
|
|
2024
Q2 | $48.8K | Buy |
+2,188
| New | +$48.8K | ﹤0.01% | 267 |
|
|
2022
Q2 | – | Sell |
-2,188
| Closed | -$657K | – | 356 |
|
|
2022
Q1 | $657K | Buy |
+2,188
| New | +$657K | 0.04% | 194 |
|
|
2019
Q4 | – | Sell |
-402
| Closed | -$372K | – | 321 |
|
|
2019
Q3 | $372K | Buy |
+402
| New | +$372K | 0.04% | 206 |
|